Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Thyroid Neoplasms 2Thoracic Neoplasms 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms, Nerve Tissue 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasms 2Lung Diseases 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Medullary 2Carcinoma, Bronchogenic 2Carcinoma 2Adenocarcinoma 2Thyroid Diseases 1Thyroid Cancer, Papillary 1Solid Tumors 1Neuroendocrine Tumors 1Neuroectodermal Tumors 1Neoplasms, Glandular and Epithelial 1Multiple Endocrine Neoplasia Type 2a 1Locally Advanced Thyroid Gland Carcinoma 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Diseases 1Endocrine System Diseases 1

Interventions

vandetanib 1trametinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1donafenib 1dabrafenib 1cabozantinib 1apatinib 1anlotinib 1Sorafenib 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Thyroid Gland Carcinoma × pralsetinib × Clear all
NCT06482086 2024-12-05

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

West China Hospital

Phase 2 Recruiting
75 enrolled
Head & Neck

Locally Advanced Thyroid Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡